Fertility Medicines Market, Global Outlook and Forecast 2024-2030
Report Code: KNJ1766177 No. of Pages: 117 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This research report provides a comprehensive analysis of the Fertility Medicines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fertility Medicines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fertility Medicines, challenges faced by the industry, and potential opportunities for market players.
The global Fertility Medicines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fertility Medicines market presents opportunities for various stakeholders, including Clinic, Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fertility Medicines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fertility Medicines market was valued at US$ 4373.3 million in 2023 and is projected to reach US$ 6566.9 million by 2030, at a CAGR of 6.1% during the forecast period.
Infertility continues to pose a global health challenge due to demographic changes and ongoing lifestyle issues, including obesity, anxiety, stress and other factors that lead to delayed childbearing. For example, according to alcoholic beverage consumption statistics released in February 2023, approximately 63% of adults aged 18 and older in the United States drank alcohol between 2021 and 2022. Additionally, 12.5% of adults in the UK reported teetotaling, while the drinking rate among adults in the country was 71.2% (drinking at least once a week), according to data released by UK Alcohol Consumption Statistics in February 2023. Therefore, heavy drinking can affect fertility in both men and women. In turn, it is expected to boost demand for infertility drugs over the forecast period.
The low fertility rate prevalent among the population is also a key factor driving the market growth. For example, in July 2022, about 15% of U.S. couples and at least 180 million people worldwide were suffering from infertility, according to an article published by the U.S. National Library of Medicine.
Key Features:
The research report on the Fertility Medicines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fertility Medicines market.
Market Overview: The report provides a comprehensive overview of the Fertility Medicines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Parenteral, Oral), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fertility Medicines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fertility Medicines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fertility Medicines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fertility Medicines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fertility Medicines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fertility Medicines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fertility Medicines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fertility Medicines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fertility Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Parenteral
Oral
Others
Market segment by Application
Clinic
Hospitals
Global Fertility Medicines Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Bayer AG
Pfizer Inc.
Abbott
Teva Pharmaceutical Industries
Livzon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fertility Medicines, market overview.
Chapter 2: Global Fertility Medicines market size in revenue and volume.
Chapter 3: Detailed analysis of Fertility Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fertility Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fertility Medicines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Fertility Medicines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fertility Medicines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fertility Medicines Overall Market Size
2.1 Global Fertility Medicines Market Size: 2023 VS 2030
2.2 Global Fertility Medicines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Fertility Medicines Sales: 2019-2030
3 Company Landscape
3.1 Top Fertility Medicines Players in Global Market
3.2 Top Global Fertility Medicines Companies Ranked by Revenue
3.3 Global Fertility Medicines Revenue by Companies
3.4 Global Fertility Medicines Sales by Companies
3.5 Global Fertility Medicines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Fertility Medicines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Fertility Medicines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fertility Medicines Players in Global Market
3.8.1 List of Global Tier 1 Fertility Medicines Companies
3.8.2 List of Global Tier 2 and Tier 3 Fertility Medicines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Fertility Medicines Market Size Markets, 2023 & 2030
4.1.2 Parenteral
4.1.3 Oral
4.1.4 Others
4.2 By Type - Global Fertility Medicines Revenue & Forecasts
4.2.1 By Type - Global Fertility Medicines Revenue, 2019-2024
4.2.2 By Type - Global Fertility Medicines Revenue, 2025-2030
4.2.3 By Type - Global Fertility Medicines Revenue Market Share, 2019-2030
4.3 By Type - Global Fertility Medicines Sales & Forecasts
4.3.1 By Type - Global Fertility Medicines Sales, 2019-2024
4.3.2 By Type - Global Fertility Medicines Sales, 2025-2030
4.3.3 By Type - Global Fertility Medicines Sales Market Share, 2019-2030
4.4 By Type - Global Fertility Medicines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Fertility Medicines Market Size, 2023 & 2030
5.1.2 Clinic
5.1.3 Hospitals
5.2 By Application - Global Fertility Medicines Revenue & Forecasts
5.2.1 By Application - Global Fertility Medicines Revenue, 2019-2024
5.2.2 By Application - Global Fertility Medicines Revenue, 2025-2030
5.2.3 By Application - Global Fertility Medicines Revenue Market Share, 2019-2030
5.3 By Application - Global Fertility Medicines Sales & Forecasts
5.3.1 By Application - Global Fertility Medicines Sales, 2019-2024
5.3.2 By Application - Global Fertility Medicines Sales, 2025-2030
5.3.3 By Application - Global Fertility Medicines Sales Market Share, 2019-2030
5.4 By Application - Global Fertility Medicines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Fertility Medicines Market Size, 2023 & 2030
6.2 By Region - Global Fertility Medicines Revenue & Forecasts
6.2.1 By Region - Global Fertility Medicines Revenue, 2019-2024
6.2.2 By Region - Global Fertility Medicines Revenue, 2025-2030
6.2.3 By Region - Global Fertility Medicines Revenue Market Share, 2019-2030
6.3 By Region - Global Fertility Medicines Sales & Forecasts
6.3.1 By Region - Global Fertility Medicines Sales, 2019-2024
6.3.2 By Region - Global Fertility Medicines Sales, 2025-2030
6.3.3 By Region - Global Fertility Medicines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Fertility Medicines Revenue, 2019-2030
6.4.2 By Country - North America Fertility Medicines Sales, 2019-2030
6.4.3 US Fertility Medicines Market Size, 2019-2030
6.4.4 Canada Fertility Medicines Market Size, 2019-2030
6.4.5 Mexico Fertility Medicines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Fertility Medicines Revenue, 2019-2030
6.5.2 By Country - Europe Fertility Medicines Sales, 2019-2030
6.5.3 Germany Fertility Medicines Market Size, 2019-2030
6.5.4 France Fertility Medicines Market Size, 2019-2030
6.5.5 U.K. Fertility Medicines Market Size, 2019-2030
6.5.6 Italy Fertility Medicines Market Size, 2019-2030
6.5.7 Russia Fertility Medicines Market Size, 2019-2030
6.5.8 Nordic Countries Fertility Medicines Market Size, 2019-2030
6.5.9 Benelux Fertility Medicines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Fertility Medicines Revenue, 2019-2030
6.6.2 By Region - Asia Fertility Medicines Sales, 2019-2030
6.6.3 China Fertility Medicines Market Size, 2019-2030
6.6.4 Japan Fertility Medicines Market Size, 2019-2030
6.6.5 South Korea Fertility Medicines Market Size, 2019-2030
6.6.6 Southeast Asia Fertility Medicines Market Size, 2019-2030
6.6.7 India Fertility Medicines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Fertility Medicines Revenue, 2019-2030
6.7.2 By Country - South America Fertility Medicines Sales, 2019-2030
6.7.3 Brazil Fertility Medicines Market Size, 2019-2030
6.7.4 Argentina Fertility Medicines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Fertility Medicines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Fertility Medicines Sales, 2019-2030
6.8.3 Turkey Fertility Medicines Market Size, 2019-2030
6.8.4 Israel Fertility Medicines Market Size, 2019-2030
6.8.5 Saudi Arabia Fertility Medicines Market Size, 2019-2030
6.8.6 UAE Fertility Medicines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Allergan Plc
7.1.1 Allergan Plc Company Summary
7.1.2 Allergan Plc Business Overview
7.1.3 Allergan Plc Fertility Medicines Major Product Offerings
7.1.4 Allergan Plc Fertility Medicines Sales and Revenue in Global (2019-2024)
7.1.5 Allergan Plc Key News & Latest Developments
7.2 Ferring BV
7.2.1 Ferring BV Company Summary
7.2.2 Ferring BV Business Overview
7.2.3 Ferring BV Fertility Medicines Major Product Offerings
7.2.4 Ferring BV Fertility Medicines Sales and Revenue in Global (2019-2024)
7.2.5 Ferring BV Key News & Latest Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Company Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Fertility Medicines Major Product Offerings
7.3.4 Merck KGaA Fertility Medicines Sales and Revenue in Global (2019-2024)
7.3.5 Merck KGaA Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Fertility Medicines Major Product Offerings
7.4.4 Novartis AG Fertility Medicines Sales and Revenue in Global (2019-2024)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Fertility Medicines Major Product Offerings
7.5.4 Sanofi Fertility Medicines Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Bayer AG
7.6.1 Bayer AG Company Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Fertility Medicines Major Product Offerings
7.6.4 Bayer AG Fertility Medicines Sales and Revenue in Global (2019-2024)
7.6.5 Bayer AG Key News & Latest Developments
7.7 Pfizer Inc.
7.7.1 Pfizer Inc. Company Summary
7.7.2 Pfizer Inc. Business Overview
7.7.3 Pfizer Inc. Fertility Medicines Major Product Offerings
7.7.4 Pfizer Inc. Fertility Medicines Sales and Revenue in Global (2019-2024)
7.7.5 Pfizer Inc. Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Fertility Medicines Major Product Offerings
7.8.4 Abbott Fertility Medicines Sales and Revenue in Global (2019-2024)
7.8.5 Abbott Key News & Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Fertility Medicines Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Fertility Medicines Sales and Revenue in Global (2019-2024)
7.9.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.10 Livzon
7.10.1 Livzon Company Summary
7.10.2 Livzon Business Overview
7.10.3 Livzon Fertility Medicines Major Product Offerings
7.10.4 Livzon Fertility Medicines Sales and Revenue in Global (2019-2024)
7.10.5 Livzon Key News & Latest Developments
8 Global Fertility Medicines Production Capacity, Analysis
8.1 Global Fertility Medicines Production Capacity, 2019-2030
8.2 Fertility Medicines Production Capacity of Key Manufacturers in Global Market
8.3 Global Fertility Medicines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fertility Medicines Supply Chain Analysis
10.1 Fertility Medicines Industry Value Chain
10.2 Fertility Medicines Upstream Market
10.3 Fertility Medicines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fertility Medicines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com